A carregar...
The Discovery and Development of Boceprevir: A Novel, First-generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease
An estimated 2–3% of the world's population is infected with hepatitis C virus (HCV), making it a major global health problem. Consequently, over the past 15 years, there has been a concerted effort to understand the pathophysiology of HCV infection and the molecular virology of replication, an...
Na minha lista:
| Publicado no: | J Clin Transl Hepatol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
XIA & HE Publishing Ltd
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4548358/ https://ncbi.nlm.nih.gov/pubmed/26357603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2013.002XX |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|